News - Vyuhpharma - Strategic consulting with an edge

Pharma News

Highlights from the Week of 08 December - 15 December VYUHPHARMA FDA approves gamida Cell's OMISIRGE as the first cell therapy for severe aplastic anemia showing rapid blood count recovery (FDA, Approval) (FDA, Approval) Fondazione Telethon ETS announces FDA approval of WASKYRA, a gene therapy for the treatment of Wiskott-Aldrich syndrome in eligible patients (FDA, Approval) amneal Amneal expands its injectables portfolio with FDA approval for EPINEPHRINE injection in single-and multi-dose vials for US hospitals (FDA, Approval) INNOVIVA antibiotic, for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents Innoviva Specialty Therapeutics announces FDA approval of NUZOLVENCE, a single-dose, oral Pg 1/5

📢Highlights from the Week of 08 December – 15 December in the world of pharma and healthcare! 🗞️👀

December 16, 2025

Highlights from the Week of 02 Dec 2025 – 08 Dec 2025 accord ( EU , Launch ) Accord Healthcare launches its denosumab biosimilars, OSVYRTI and JUBEREQ, in Europe for bone health conditions like osteoporosis FRESENIUS KABI ( FDA, Approval ) Fresenius Kabi's partner, SamChunDang Pharm, receives FDA acceptance to review its proposed aflibercept biosimilar for ophthalmic disorders SAMSUNG BIOEPIS ( EMA, Approval ) Samsung Bioepis' pre-filled syringe presentation of its Lucentis biosimilar, BYOOVIZ, receives European approval Hope Medicine ( FDA, Fast Track ) Hope Medicine's HMI-115 gains FDA Fast Track status, accelerating global development for endometriosis pain All logos and trademarks remain the intellectual properties of their respective owners

📢Highlights from the Week of 02 Dec 2025 – 08 Dec 2025, 2025 in the world of pharma and healthcare! 🗞️👀

December 9, 2025

$VYUHPHARMA Highlights from the Week of November 10-17, 2025 ORGANON Organon and Henlius received FDA approval for their biosimilar, POHERDY, as the first interchangeable biosimilar to Roche's Perjeta, for use in HER2-positive breast cancer indications Pan amneal Amneal Pharmaceuticals received FDA approval for IOHEXOL injection, a generic radiographic contrast agent equivalent to Omnipaque, with launch expected in QI 2026 KURA ONCOLOGY The FDA granted full approval to Kura and Kyowa Kirin's oral therapy, KOMZIFTI (ziftomenib), for relapsed/refractory NPMI-mutated AML (FDA, Approval) (FDA, Approval) Pg 1/3 (FDA, Approval) All logos and trademarks remain the intellectual properties of their respective owners$

📢Highlights from the Week of 10 November – 17 November 2025 in the world of pharma and healthcare! 🗞️👀

November 17, 2025

Investor calendar

INVESTOR CALENDER OF THE WEEK December 10,2025 To December 11,2025 Regeneron Roundtable: Lynozyfic Virtual Oncology/SABCS Investor Event December 10 December 11 Virtual Investor Presentation on Hematology Programs December 11 All logos and trademarks remain the intellectual properties of their respective owners

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of December 10 – 11, 2025 💻

December 9, 2025

INVESTOR CALENDER OF THE WEEK Nov 17,2025 To Nov 20,2025 Jefferies London Healthcare Conference Wolfe Research 7th Annual Healthcare Conference Nov 19 Nov 17 Jefferies Global Healthcare Conference Nov 19 Nov 20 All logos and trademarks remain the intellectual properties of their respective owners

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of November 17th – 20th, 2025 💻

November 17, 2025

INVESTOR CALENDER OF THE WEEK November 10th - 12th, 2025 Guggenheim 2nd Annual Healthcare Innovation Conference Nov 10 AstraZeneca Nov 11 Johnson&Johnson NOVARTIS Nav 12 Roche UBS European Conference Nov 11 Roche UBS Global Healthcare Conference Nov 11 Johnson&Johnson Nav 12 GSK AstraZeneca Visit our website for more updates | www.vyuhpharma.com All logos and trademarks remain the intellectual properties of their respective owners

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of November 10th – 12th, 2025 💻

November 10, 2025

Pharma News

📢Highlights from the Week of 08 December – 15 December in the world of pharma and healthcare! 🗞️👀

📢Highlights from the Week of 02 Dec 2025 – 08 Dec 2025, 2025 in the world of pharma and healthcare! 🗞️👀

📢Highlights from the Week of 10 November – 17 November 2025 in the world of pharma and healthcare! 🗞️👀

Investor calendar

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of December 10 – 11, 2025 💻

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of November 17th – 20th, 2025 💻

📢 Attention ⏰ Stay up to date with the latest investor calls by checking out our calendar for the week of November 10th – 12th, 2025 💻

Healthcare Insights

The Pharma BI division of

Vyuhgenics Inc.

Connect with us